Commercial Manufacturing. Roche shall be solely and exclusively responsible at its own expense for commercial manufacture of Products, either itself or through Third Parties.
Commercial Manufacturing. (a) Commercial Supply Agreement. No later than [****] prior to the anticipated First Commercial Sale of a Collaboration Product as specified in the Commercialization Plan for such Collaboration Product, PDL and Biogen Idec shall negotiate in good faith one or more definitive supply agreements (each, a “Commercial Supply Agreement”). Each such agreement will set forth the specific terms and conditions governing the supply of bulk and/or finished Collaboration Products by the Parties for commercial use. Any Commercial Supply Agreement shall include terms substantially similar to those set forth in Exhibit 8.3 as well as additional reasonable and customary terms relating to commercial supply.
Commercial Manufacturing. CAPSUGEL shall manufacture the Product for each Marketer unless otherwise agreed by the Parties and the applicable Marketer.
Commercial Manufacturing. If Customer wishes Lonza to perform, and Lonza is willing to perform, any manufacturing for commercial supply, the Parties shall use their reasonable endeavours to agree the terms of an appropriate commercial supply agreement.
Commercial Manufacturing. Based upon the successfully completed technology transfer of the Product in accordance with the provisions stated in the Proposal No. DPM-FCG1-1201-0206-R1, during the term of and subject to the terms and conditions of this Agreement, DEPOMED hereby grants MOVA the exclusive right to manufacture and package DEPOMED’s requirements for the USA of the Product, and MOVA hereby agrees to timely manufacture and package such requirements of Product for DEPOMED. At such time as DEPOMED first seeks manufacturing services of a nature similar to those provided by MOVA under this Agreement to meet the need for Product supply in a country or geographical region, as the case may be, where Product has not previously been sold, DEPOMED shall offer to MOVA the opportunity to discuss its capabilities relating to such supply outside the U.S.A. and to make a proposal to DEPOMED in such regard.
Commercial Manufacturing. Effective on the Effective Date and subject to Section 4.5(c) and this Section 4.5(b), each party shall each be solely responsible for the manufacturing of all Daclizumab necessary to satisfy the commercial requirements of itself, its Affiliates and its sublicensees. [*] shall keep [*] reasonably informed, via the POC, regarding its progress in [*] for its [*] to [*] for [*]. As needed, the parties shall discuss and agree upon a plan of action to address, among other things, [*] that could arise if [*] progress in [*] is delayed, which plan could include for [*] to supply commercial requirements to [*] on a [*] basis.
Commercial Manufacturing. LILLY and ISIS will work together to complete a plan for commercial supply of API. LILLY and ISIS will work together to identify and investigate other sources for the manufacture of API to be utilized for Commercial Product. LILLY will inform ISIS in writing by July 1, 2002 of LILLY's decision, at its sole discretion, regarding whether LILLY, ISIS and/or a third party will manufacture API to be utilized for Commercial Product, and which of them shall be the primary source and the back-up source of API to be utilized for Commercial Product. If, in such notice, LILLY elects to have ISIS manufacture API to be utilized for Commercial Product, LILLY and ISIS will negotiate in good faith, and ISIS hereby commits, for ISIS to manufacture API to be utilized for Commercial Product on substantially the terms set forth in Exhibit 8. In such notice, LILLY will also provide LILLY's API order estimates for Calendar Years 2003, 2004 and 2005.
Commercial Manufacturing. Effective on the Effective Date and subject to Section 4.5(c) and this Section 4.5(b), each party shall each be solely responsible for the manufacturing of all Daclizumab necessary to satisfy the commercial requirements of itself, its Affiliates and its sublicensees. [CONFIDENTIAL TREATMENT REQUESTED]
Commercial Manufacturing. PDL shall be solely responsible for the manufacturing of all Daclizumab, except that Roche shall be solely responsible for the manufacturing of all Nutley Dac, necessary to satisfy the commercial requirements of itself, its Affiliates and its sublicensees.
Commercial Manufacturing. Subject to the terms and conditions of this Agreement, COLLABORATOR, on behalf of itself and its Affiliates, hereby grants to BMS a co-exclusive (with BMS and its Affiliates), royalty-free right and license, with the right to grant sublicenses as set forth in Section 10.4, under the COLLABORATOR Technology and its interest in the Joint Collaboration Technology, in each case solely to make and have made Apixaban Compounds, Apixaban Products, BMS New Collaboration Compounds, and BMS New Collaboration Products anywhere in the world for use, sale, marketing, promotion and other Commercialization purposes, for Phase IV Clinical Trials, and for compassionate use/indigent access purposes in each case solely in the Unmodified Territory. [*] = Portions of this exhibit have been omitted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Securities and Exchange Commission.
